It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2001.
2001 | Mumbai, Maharashtra, India | ActiveSerena Pharma Private Limited, a active private limited company, was established on 03 April 2001 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24239MH2001PTC131489. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.20 M.
It upholds a compliant status. Its leadership includes Sujit Kumar Singh (Director), Himanshu Baldev Singh (Director). Past directors included Sheel Kumar Dhananjay Singh, Radhe Krishan Nagpal, Shirish Rajaram Gholkar. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shreya House 4Th Floor301/A Pereira Hill Road Andheri (West), Mumbai, Maharashtra, 400099.
U24239MH2001PTC131489
131489
03 April 2001
₹1.00 M
₹0.20 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Serena Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sujit Kumar Singh | Director | 03 Apr 2001 | Current |
| Himanshu Baldev Singh | Director | 06 Nov 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 Mar 2019 | Past |
| Pramod Abcsdd | Director | 06 Nov 2009 | Past |
| Pramod Abcsdd | Director | 01 Dec 2008 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Serena Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 173.4% decrease in profit. The company's net worth dipped by a decrease of 8%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Serena Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Serena Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Serena Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Serena Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Serena Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Serena Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
The activity Himanshu Baldev Singh was appointed as a Director was appointed as a Director on 06 Nov 2009 & has been associated with this company since 16 years 25 days . was completed.
Progress on Sujit Kumar Singh was appointed as a Director was appointed as a Director on 03 Apr 2001 & has been associated with this company since 24 years 7 months . was documented.
Serena Pharma Private Limited was registered on 03 Apr 2001 with Roc Mumbai & aged 24 years 7 months as per MCA records. was recorded as a recent event.
The CIN of Serena Pharma Private Limited is U24239MH2001PTC131489.
Serena Pharma Private Limited is headquartered at Shreya House 4Th Floor301/A Pereira Hill Road Andheri (West), Mumbai, Maharashtra, 400099.
Serena Pharma Private Limited was incorporated on 03 April 2001.
The current directors of Serena Pharma Private Limited are
The primary industry of Serena Pharma Private Limited is Pharma.
Serena Pharma Private Limited is unlisted.
The authorized capital of Serena Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.20 M.
The compliance status of Serena Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX